Opinion
Published on 24 Aug 2022
Current advances in our understanding of circular RNA (circRNA) in Alzheimer’s disease (AD); the potential utilization of synthetic circRNAs as a therapeutic strategy in the clinical management of AD
in Technologies and Strategies to Enable Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.983030
- 2,133 views
- 9 citations